▲
STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #2138 by analyst upside · 2026-08-13
ARGX
argenx SE
Healthcare · Market Cap $54B · P/E 32.9x
ANALYST PRICE TARGET
+23.9%
implied upside to consensus target
Current Price $876.0
Consensus Target $1085.78
Bull Target $1350.0
Bear Target $770.0
Analysts Covering 23
ANALYST CONSENSUS - BUY
Strong Buy
6
Buy
14
Hold
3
Sell
0
52-Week Low $637.04
52-Week High $953.58
YTD Return +4.3%
FUNDAMENTALS
Market Cap $54B
P/E Ratio (TTM) 32.9x
Forward P/E 22.1x
EPS (TTM) $26.63
PEG Ratio 1.32
Dividend Yield N/A
Revenue (TTM) $5.3B
Profit Margin 32.3%
52-WEEK RANGE
52-Week Low $637.04
52-Week High $953.58
Current Price $876.0
Bear Target $770.0
Bull Target $1350.0
● Now $876.0 ● Target $1085.78
TRADING DATA
Avg Volume 332K
YTD Return +4.3%
Analyst Count 23
Consensus Buy
Upside to Target +23.9%
Last Updated 2026-08-13

ANALYST SUMMARY

argenx SE (ARGX) is currently trading at $876.0 with a Wall Street consensus price target of $1085.78, implying potential upside of 23.9% over the next 12 months. 23 analysts currently cover ARGX, with a consensus rating of Buy - 87% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $1350.0, while the most cautious has a target of $770.0.

ARGX operates in the Healthcare sector with a market capitalisation of $54B. The stock is up 4.3% year-to-date and is currently trading near the upper end of its 52-week range of $637.04 – $953.58.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

CAH +7.8%
Cardinal Health, Inc.
$54B · P/E 32.4x · Buy
BDX +4.6%
Becton, Dickinson and Company
$50B · P/E 31.3x · Buy
COR +18.6%
Cencora, Inc.
$60B · P/E 23.4x · Buy
HUM +7.1%
Humana Inc.
$47B · P/E 36.7x · Buy
A +7.5%
Agilent Technologies, Inc.
$42B · P/E 30.0x · Buy

RECENT ANALYST CALLS

Upgrade/downgrade history for ARGX, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Wedbush reit
Outperform → Outperform 2026-06-11 Building track record
Wedbush reit
Outperform → Outperform 2026-06-04 Building track record
Wells Fargo - Reiterated
Overweight → Overweight 2026-06-01 Building track record
Evercore ISI Group - Reiterated
Outperform → Outperform 2026-05-15 Building track record
Guggenheim - Reiterated
Buy → Buy 2026-05-08 62% win rate (8 calls)
Wells Fargo - Reiterated
Overweight → Overweight 2026-05-08 Building track record
Oppenheimer - Reiterated
Outperform → Outperform 2026-04-02 14% win rate (7 calls)
Wedbush reit
Outperform → Outperform 2026-03-09 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
63
out of 100
Coverage depth
24/30
Consensus clarity
17/30
Vote unanimity
20/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →